Specialty Area
Spotlight
Topics
Institute for Value-Based Medicine
About AJMC
Podcasts
CE
Subscribe
- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
The Evolving Role of Subcutaneous Therapies in NSCLC : Episode 12
Barriers to Adoption of SC Therapies
Panelists discuss how overcoming logistical and perceptual barriers will drive wider adoption of SC therapies in NSCLC.
EP: 1.Understanding EGFR Mutations and First-Line Treatment
EP: 2.Overcoming Resistance Mechanisms and Addressing Unmet Needs
EP: 3.Impact of Recent Approvals and Novel Mechanisms
EP: 4.CNS Penetration and Efficacy of Emerging Therapies
EP: 5.Managing Adverse Events and Integrating Amivantamab Plus Lazertinib
EP: 6.Sequencing Therapies and Using the Most Effective Options First
EP: 7.The Value of Subcutaneous Therapy for Patients
EP: 8.FDA Approvals, Patient Selection, and SC Amivantamab
EP: 9.Counseling Patients on IV vs SC Administration
EP: 10.Improving Adherence and Transitioning to SC Therapy
EP: 11.Impact of SC Formulations on Pharmacy Operations
Now Viewing
EP: 12.Barriers to Adoption of SC Therapies
Panelists discuss how barriers such as provider hesitancy, reimbursement concerns, and logistical complexities slow the adoption of subcutaneous (SC) therapies. They propose strategies including education, workflow redesign, and advocacy to increase confidence in SC delivery. The discussion emphasizes that as data accumulate and experience grows, institutional and cultural shifts will further integrate SC therapy
Related Videos
Related Content
